Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142756 |
| CAS No | NA |
| Mol.F. | C12H10N2O5S |
| Mol.Wt. | 294.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142757 |
| CAS No | NA |
| Mol.F. | C18H18N2O3 |
| Mol.Wt. | 310.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142758 |
| CAS No | NA |
| Mol.F. | C18H19N3O2 |
| Mol.Wt. | 309.37 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142759 |
| CAS No | NA |
| Mol.F. | C38H39N3O4 |
| Mol.Wt. | 601.75 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142760 |
| CAS No | NA |
| Mol.F. | C28H29N3O3 |
| Mol.Wt. | 455.56 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142761 |
| CAS No | NA |
| Mol.F. | C38H39N3O4 |
| Mol.Wt. | 601.75 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142762 |
| CAS No | NA |
| Mol.F. | C47H49N5O4 |
| Mol.Wt. | 747.94 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142763 |
| CAS No | 68962-15-2 |
| Mol.F. | C12H9ClN2O |
| Mol.Wt. | g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142764 |
| CAS No | NA |
| Mol.F. | C13H8Cl2N2O3 |
| Mol.Wt. | 311.12 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142765 |
| CAS No | NA |
| Mol.F. | C14H10Cl2N2O3 |
| Mol.Wt. | 325.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142766 |
| CAS No | NA |
| Mol.F. | C8H6N2O2 |
| Mol.Wt. | 162.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142767 |
| CAS No | NA |
| Mol.F. | C14H9Cl3N2O2 |
| Mol.Wt. | 343.59 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142768 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O5 |
| Mol.Wt. | 399.22 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142769 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O3 |
| Mol.Wt. | 367.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142770 |
| CAS No | NA |
| Mol.F. | C14H8Cl2N2O4 |
| Mol.Wt. | 339.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142771 |
| CAS No | NA |
| Mol.F. | C14H10BrClN203 |
| Mol.Wt. | 369.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |